REVOLUTION MEDICINES INC (RVMD)
US76155X1000 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.39M -31.62% | 35.38M 20.38% | 11.58M -67.27% | 327.859K -97.17% | 6.411M 1,855.42% | 20.793M 224.33% | 205.56M 888.60% | 674.84M 228.29% | 1.508B 123.46% | 2.801B 85.74% | 4.77B 70.30% | |
| EBITDA YoY % growth | -183.86M -71.80% | -253.24M -37.74% | -481.075M -89.97% | -672.037M -39.69% | -749.46M -11.52% | -796.357M -6.26% | -894.407M -12.31% | -495.547M 44.59% | -190.536M 61.55% | 945.23M 596.09% | 2.512B 165.76% | |
| EBIT YoY % growth | -188.01M -69.84% | -258.28M -37.38% | -487.185M -88.63% | -674M -38.35% | -739.783M -9.76% | -768.492M -3.88% | -645.268M 16.03% | -255.87M 60.35% | 311.49M 221.74% | 1.309B 320.24% | 2.837B 116.73% | |
| Operating Margin | -639.71% | -730.02% | -4,207.12% | -205,576.29% | -11,539.27% | -3,695.92% | -313.91% | -37.92% | 20.66% | 46.73% | 59.48% | |
| EPS YoY % growth | -2.56 -19.63% | -3.10 -21.09% | -3.77 -21.71% | -3.55 5.94% | -4.03 -13.47% | -4.22 -4.83% | -3.03 28.20% | -0.81 73.25% | 1.77 318.03% | 8.26 367.13% | 16.69 102.06% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.02 10.54% | -1.01 -43.71% | -1.04 -28.60% | -1.07 -13.43% | -1.10 -7.90% | -1.12 -11.23% | -1.09 -4.58% | -1.09 -2.64% | -1.11 -1.31% |
| Revenue Q2Q % growth | 353.073K -52.42% | -100.00% | N/A | N/A | 1.042M | 5.84M | |||
| EBITDA Q2Q % growth | -194.82M -12.05% | -207.06M -48.91% | -208.08M -36.06% | -209.1M -22.94% | -210.12M -7.85% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -185.476M -3.05% | -183.132M -30.01% | -188.823M -20.54% | -195.061M -11.01% | -200.045M -7.85% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.94 5.34% | -0.91 | -0.03 | -3.17% |
| Q2 2024 Q2Q % growth | -0.81 11.96% | -0.79 | -0.02 | -2.48% |
| Q1 2024 Q2Q % growth | -0.70 2.78% | -0.76 | 0.06 | 8.02% |
| Q4 2023 Q2Q % growth | -1.14 -80.95% | -0.90 | -0.24 | -26.70% |
| Q3 2023 Q2Q % growth | -0.99 -14.14% | -1.03 | 0.03 | 3.23% |
| Q2 2023 Q2Q % growth | -0.92 -12.20% | -0.84 | -0.08 | -9.49% |
| Q1 2023 Q2Q % growth | -0.72 7.69% | -0.83 | 0.11 | 13.23% |
| Q4 2022 Q2Q % growth | -0.63 11.27% | -0.84 | 0.21 | 24.84% |
| Q3 2022 Q2Q % growth | -0.87 -20.83% | -0.86 | -0.01 | -1.27% |
| Q2 2022 Q2Q % growth | -0.82 -36.67% | -0.87 | 0.05 | 5.39% |
| Q1 2022 Q2Q % growth | -0.78 -47.17% | -0.79 | 0.01 | 1.31% |
| Q4 2021 Q2Q % growth | -0.71 -36.54% | -0.65 | -0.06 | -9.01% |
| Q3 2021 Q2Q % growth | -0.72 -71.43% | -0.64 | -0.08 | -12.86% |
| Q2 2021 Q2Q % growth | -0.60 -30.43% | -0.57 | -0.03 | -5.04% |
| Q1 2021 Q2Q % growth | -0.53 28.38% | -0.53 | 0.00 | 0.84% |
| Q4 2020 Q2Q % growth | -0.52 92.02% | -0.39 | -0.13 | -32.76% |
| Q3 2020 Q2Q % growth | -0.42 | -0.40 | -0.02 | -5.04% |
| Q2 2020 Q2Q % growth | -0.46 | -0.37 | -0.09 | -24.58% |
| Q1 2020 Q2Q % growth | -0.74 | -0.34 | -0.40 | -118.19% |
| Q4 2019 Q2Q % growth | -6.52 | -0.42 | -6.10 | -1,459.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 327.859K | -327.859K | -100.00% | |
| Q2 2024 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q1 2024 Q2Q % growth | -100.00% | 1.404M | -1.404M | -100.00% |
| Q4 2023 Q2Q % growth | 742K -95.16% | 1.113M | -371K | -33.33% |
| Q3 2023 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q2 2023 Q2Q % growth | 3.824M -58.07% | 1.594M | 2.23M | 139.90% |
| Q1 2023 Q2Q % growth | 7.014M -7.47% | 2.996M | 4.018M | 134.11% |
| Q4 2022 Q2Q % growth | 15.33M 62.05% | 7.908M | 7.422M | 93.85% |
| Q3 2022 Q2Q % growth | 3.36M 205.45% | 6.406M | -3.046M | -47.55% |
| Q2 2022 Q2Q % growth | 9.12M 4.83% | 7.159M | 1.961M | 27.39% |
| Q1 2022 Q2Q % growth | 7.58M -25.17% | 8.67M | -1.09M | -12.57% |
| Q4 2021 Q2Q % growth | 9.46M 8.11% | 9.096M | 364K | 4.00% |
| Q3 2021 Q2Q % growth | 1.1M -91.31% | 8.874M | -7.774M | -87.60% |
| Q2 2021 Q2Q % growth | 8.7M -13.26% | 9.571M | -871K | -9.10% |
| Q1 2021 Q2Q % growth | 10.13M -12.29% | 9.649M | 481K | 4.98% |
| Q4 2020 Q2Q % growth | 8.75M -27.63% | 17.116M | -8.366M | -48.88% |
| Q3 2020 Q2Q % growth | 12.66M 1.20% | 14.525M | -1.865M | -12.84% |
| Q2 2020 Q2Q % growth | 10.03M -18.32% | 13.627M | -3.597M | -26.40% |
| Q1 2020 Q2Q % growth | 11.55M -12.30% | 13.643M | -2.093M | -15.34% |
| Q4 2019 Q2Q % growth | 12.09M 16.81% | 13.107M | -1.017M | -7.76% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -21.93% | -1.02% | -0.71% |
| Revenue | 0% | -79.46% | 7.14% | -78.57% |